A Small-Molecule Microarray Approach for the Identification of E2 Enzyme Inhibitors in Ubiquitin-Like Conjugation Pathways
E2 enzymes in ubiquitin-like conjugation pathways are important, highly challenging pharmacological targets, and despite significant efforts, few noncovalent modulators have been discovered. Small-molecule microarray (SMM)-based screening was employed to identify an inhibitor of the "undruggable" small ubiquitin-like modifier (SUMO) E2 enzyme Ubc9. The inhibitor, a degradation product from a commercial screening collection, was chemically synthesized and evaluated in biochemical, mechanistic, and structure-activity relationship studies. Binding to Ubc9 was confirmed through the use of ligand-detected nuclear magnetic resonance, and inhibition of sumoylation in a reconstituted enzymatic cascade was found to occur with an IC50 of 75 µM. This work establishes the utility of the SMM approach for identifying inhibitors of E2 enzymes, targets with few known small-molecule modulators.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
SLAS discovery : advancing life sciences R & D - 22(2017), 6 vom: 24. Juli, Seite 760-766 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zlotkowski, Katherine [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 21.02.2019 Date Revised 30.08.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1177/2472555216683937 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM270347844 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM270347844 | ||
| 003 | DE-627 | ||
| 005 | 20231224230352.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/2472555216683937 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0901.xml |
| 035 | |a (DE-627)NLM270347844 | ||
| 035 | |a (NLM)28346086 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zlotkowski, Katherine |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Small-Molecule Microarray Approach for the Identification of E2 Enzyme Inhibitors in Ubiquitin-Like Conjugation Pathways |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.02.2019 | ||
| 500 | |a Date Revised 30.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a E2 enzymes in ubiquitin-like conjugation pathways are important, highly challenging pharmacological targets, and despite significant efforts, few noncovalent modulators have been discovered. Small-molecule microarray (SMM)-based screening was employed to identify an inhibitor of the "undruggable" small ubiquitin-like modifier (SUMO) E2 enzyme Ubc9. The inhibitor, a degradation product from a commercial screening collection, was chemically synthesized and evaluated in biochemical, mechanistic, and structure-activity relationship studies. Binding to Ubc9 was confirmed through the use of ligand-detected nuclear magnetic resonance, and inhibition of sumoylation in a reconstituted enzymatic cascade was found to occur with an IC50 of 75 µM. This work establishes the utility of the SMM approach for identifying inhibitors of E2 enzymes, targets with few known small-molecule modulators | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, N.I.H., Intramural | |
| 650 | 4 | |a E2 enzymes | |
| 650 | 4 | |a Ubc9 | |
| 650 | 4 | |a small-molecule microarray | |
| 650 | 4 | |a sumoylation | |
| 650 | 7 | |a Enzyme Inhibitors |2 NLM | |
| 650 | 7 | |a Small Molecule Libraries |2 NLM | |
| 650 | 7 | |a Ubiquitin-Conjugating Enzymes |2 NLM | |
| 650 | 7 | |a EC 2.3.2.23 |2 NLM | |
| 650 | 7 | |a ubiquitin-conjugating enzyme UBC9 |2 NLM | |
| 650 | 7 | |a EC 6.3.2.- |2 NLM | |
| 700 | 1 | |a Hewitt, William M |e verfasserin |4 aut | |
| 700 | 1 | |a Sinniah, Ranu S |e verfasserin |4 aut | |
| 700 | 1 | |a Tropea, Joseph E |e verfasserin |4 aut | |
| 700 | 1 | |a Needle, Danielle |e verfasserin |4 aut | |
| 700 | 1 | |a Lountos, George T |e verfasserin |4 aut | |
| 700 | 1 | |a Barchi, Joseph J |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Waugh, David S |e verfasserin |4 aut | |
| 700 | 1 | |a Schneekloth, John S |c Jr |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t SLAS discovery : advancing life sciences R & D |d 2017 |g 22(2017), 6 vom: 24. Juli, Seite 760-766 |w (DE-627)NLM258579609 |x 2472-5560 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2017 |g number:6 |g day:24 |g month:07 |g pages:760-766 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/2472555216683937 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2017 |e 6 |b 24 |c 07 |h 760-766 | ||